Skip to main content
Robert Moen, MD, Allergy & Immunology, Seattle, WA

RobertChasMoenMDPhD

Allergy & Immunology Seattle, WA

President & CEO Copernicus Therapeutics, Inc.

Dr. Moen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Moen's full profile

Already have an account?

  • Office

    U of WA Sch of Med
    Seattle, WA 98195

Education & Training

  • University of Washington
    University of WashingtonPhD, Biochemistry, 1972 - 1979
  • University of Washington
    University of WashingtonMD, Medical Scientist, 1972 - 1979
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1979
  • Harvard University
    Harvard UniversityBA, Biochemistry, Magna Cum Laude, 1972 - 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2026
  • MD State Medical License
    MD State Medical License 1990 - 2017
  • DC State Medical License
    DC State Medical License 1991 - 1992
  • WI State Medical License
    WI State Medical License 1982 - 1991
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Small Business Innovation Research Grant 1989, 1990
  • First Recipient of the Immune Deficiency Foundation Fellowship Award 1983, 1985
  • American Cancer Society Institutional Research Grant U of Wisconsin - Madison, 1984, 1985
  • Join now to see all

Publications & Presentations

Journal Articles

  • Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients.  
    Brenner, M.K., Rill, D.R., Holladay, M.S., Heslop, H.E., Moen, R.C., Buschle, M., Krance, R.A., Anderson, W.F., and Ihle, J.N, Lancet
  • Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo.  
    Ziady, A-G., Gedeon, C.R., Miller, T., Quan, W., Payne, J.M., Hyatt, S.L., Fink, T.L., Muhammad, O., Oette, S., Kowalczyk, T., Pasumarthy, M.K., Moen, R.C., Cooper, M...., Mol. Ther
  • Amphotropic murine leukemia retrovirus is not an acute pathogen for primates.  
    Cornetta, K., Moen, R.C., Culver, K., Morgan, R.A., McLachlin, J.R., Sturm, S., Selegue, J.E., London, W.T., Blaese, R.M., and Anderson, W.F, Human Gene Therapy
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Press Mentions

  • New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients with Atrial Fibrillation
    New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients with Atrial FibrillationAugust 3rd, 2021